Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives - PubMed (original) (raw)
Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives
Philip S Wang et al. Hypertension. 2005 Aug.
Abstract
Although the benefits of antihypertensive drugs have been clearly established, they remain underused by vulnerable older populations. We examined whether the presence of noncardiovascular comorbidity deters use of antihypertensives in elderly with hypertension. We conducted a retrospective cohort study among 51,517 patients > or =65 years of age in the Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PACE) Program during 1999 and 2000. All were hypertensive and had diagnoses and used treatments during 1999 to qualify for entry into 1 of the following 5 mutually exclusive cohorts: asthma/chronic obstructive pulmonary disease (COPD), depression, gastrointestinal (GI) disorders, osteoarthritis, or none of the 4 comorbidities. Proportions using antihypertensives in 2000 were assessed. Logistic regression analysis was used to identify the independent effects on antihypertensive use of the 4 comorbidities of interest, sociodemographic characteristics, other cardiovascular and noncardiovascular comorbidity, and health care utilization variables. After adjustments in multivariable analyses, antihypertensive use was consistently lower in patients with asthma/COPD (odds ratio [OR], 0.43; 95% confidence interval [CI], 0.40 to 0.47), depression (OR, 0.50; 95% CI, 0.45 to 0.55), GI disorders (OR, 0.59; 95% CI, 0.54 to 0.64), and osteoarthritis (OR, 0.63; 95% CI, 0.59 to 0.67) relative to those without these conditions. Reduced antihypertensive use was also associated with older age, female gender, white race, more severe other comorbidities, absence of some cardiovascular indications, hospitalizations, nursing home care, physician visits, and use of fewer other medications. Highly prevalent, noncardiovascular conditions appear to deter use of antihypertensives in elderly with hypertension.
Comment in
- Noncardiovascular illness as barrier to antihypertensive treatment.
Staessen JA, Thijs L, Birkenhäger WH. Staessen JA, et al. Hypertension. 2005 Aug;46(2):255-6. doi: 10.1161/01.HYP.0000172754.53463.38. Epub 2005 Jul 5. Hypertension. 2005. PMID: 15998713 No abstract available.
Similar articles
- Noncardiovascular illness as barrier to antihypertensive treatment.
Staessen JA, Thijs L, Birkenhäger WH. Staessen JA, et al. Hypertension. 2005 Aug;46(2):255-6. doi: 10.1161/01.HYP.0000172754.53463.38. Epub 2005 Jul 5. Hypertension. 2005. PMID: 15998713 No abstract available. - Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Mazzaglia G, et al. Circulation. 2009 Oct 20;120(16):1598-605. doi: 10.1161/CIRCULATIONAHA.108.830299. Epub 2009 Oct 5. Circulation. 2009. PMID: 19805653 - Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G. Mallion JM, et al. J Hum Hypertens. 2001 Dec;15(12):841-8. doi: 10.1038/sj.jhh.1001280. J Hum Hypertens. 2001. PMID: 11773986 - Managing hypertension in the elderly in light of the changes during aging.
Rosenthal T, Nussinovitch N. Rosenthal T, et al. Blood Press. 2008;17(4):186-94. doi: 10.1080/08037050802305578. Blood Press. 2008. PMID: 18663653 Review. - [Benefits of hypertension treatment in the elderly].
Girerd X, Hanon O. Girerd X, et al. Ann Cardiol Angeiol (Paris). 1999 Sep;48(7):518-22. Ann Cardiol Angeiol (Paris). 1999. PMID: 12555376 Review. French.
Cited by
- Cognitive, physical, and sensory deficits that can affect everyday medication use among older adults: A national view.
Tang B, Espejo E, Steinman MA, Growdon ME. Tang B, et al. J Am Geriatr Soc. 2024 Jul;72(7):2254-2257. doi: 10.1111/jgs.18922. Epub 2024 Apr 10. J Am Geriatr Soc. 2024. PMID: 38599615 No abstract available. - Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis.
Butterly EW, Hanlon P, Shah ASV, Hannigan LJ, McIntosh E, Lewsey J, Wild SH, Guthrie B, Mair FS, Kent DM, Dias S, Welton NJ, McAllister DA. Butterly EW, et al. PLoS Med. 2023 Jan 17;20(1):e1004154. doi: 10.1371/journal.pmed.1004154. eCollection 2023 Jan. PLoS Med. 2023. PMID: 36649256 Free PMC article. - Improving the Estimation of Subgroup Effects for Clinical Trial Participants with Multimorbidity by Incorporating Drug Class-Level Information in Bayesian Hierarchical Models: A Simulation Study.
Hannigan LJ, Phillippo DM, Hanlon P, Moss L, Butterly EW, Hawkins N, Dias S, Welton NJ, McAllister DA. Hannigan LJ, et al. Med Decis Making. 2022 Feb;42(2):228-240. doi: 10.1177/0272989X211029556. Epub 2021 Aug 18. Med Decis Making. 2022. PMID: 34407672 Free PMC article. - Medication Adherence: Expanding the Conceptual Framework.
Krousel-Wood M, Craig LS, Peacock E, Zlotnick E, O'Connell S, Bradford D, Shi L, Petty R. Krousel-Wood M, et al. Am J Hypertens. 2021 Sep 22;34(9):895-909. doi: 10.1093/ajh/hpab046. Am J Hypertens. 2021. PMID: 33693474 Free PMC article. - Does depressed persons with non-cardiovascular morbidity have a higher risk of CVD? A population-based cohort study in Sweden.
Almas A, Moller J, Iqbal R, Lundin A, Forsell Y. Almas A, et al. BMC Cardiovasc Disord. 2019 Nov 21;19(1):260. doi: 10.1186/s12872-019-1252-7. BMC Cardiovasc Disord. 2019. PMID: 31752710 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- R01-AG18833/AG/NIA NIH HHS/United States
- R01-MH69772/MH/NIMH NIH HHS/United States
- K01-MH01651/MH/NIMH NIH HHS/United States
- R03-AG18395/AG/NIA NIH HHS/United States
- K25 AG027400/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical